Sage Hospitality Denver, CO 2008 to 2011 Chief Operating OfficerW Hotels Worldwide Stamford, CT 2003 to 2007 Senior Vice PresidentLoews Hotels and Resorts New York, NY 1999 to 2001 Executive Vice President-Operations
Education:
California State College Los Angeles, CA 1970 Associate of Arts in Fine Arts
Medical School Albany Medical College Graduated: 1988 Medical School Strong Mem Hsp University Rochester Graduated: 1988 Medical School Vet Affairs Med Center Graduated: 1988
Boise Radiology Group PA 190 E Bannock St, Boise, ID 83712 2083812094 (phone), 2083811791 (fax)
Education:
Medical School University of Washington SOM Graduated: 1994
Languages:
English
Description:
Dr. Marx graduated from the University of Washington SOM in 1994. He works in Boise, ID and specializes in Diagnostic Radiology. Dr. Marx is affiliated with St Lukes Boise Medical Center and St Lukes Meridian Medical Center.
Steven Marx, New York NY
Work:
Columbia University
630 W 168Th St, New York, NY 10032 Columbia University
622 W 168Th St, New York, NY 10032
American Board of Internal Medicine Sub-certificate in Cardiovascular Disease (Internal Medicine) American Board of Internal Medicine Sub-certificate in Clinical Cardiac Electrophysiology (Internal Medicine)
Us Patents
Methods For Identifying Chemical Compounds That Inhibit Dissociation Of Fkbp12.6 Binding Protein From Type 2 Ryanodine Receptor
This invention provides methods of regulating contraction of a subjects heart and of treating heart failure and cardiac arrhythmia. This invention also provides methods of obtaining compounds that bind to, and activate or inhibit the activation of a type 2 ryanodine (RyR2) receptor, and methods for screening for compounds that alleviate heart disease.
C3 Exoenzyme-Coated Stents And Uses Thereof For Treating And Preventing Restenosis
Steven O. Marx - New York NY, US Andrew R. Marks - Larchmont NY, US
Assignee:
The Trustees of Columbia University in the City of New York - New York NY
International Classification:
A61F 2/06 A61L 33/00
US Classification:
623 142, 623 148
Abstract:
This invention provides a stent for implantation in a blood vessel or other tissue, wherein the stent is coated with or contains C3 exoenzyme, a chimeric version thereof or an inhibitor of RhoA. This invention also provides a method for treating or inhibiting the onset of restenosis in a subject which comprises implanting one of the instant stents in the subject's blood vessel.
C3 Exoenzyme-Coated Stents And Uses Thereof For Treating And Preventing Restenosis
Steven O. Marx - New York NY, US Andrew R. Marks - Larchmont NY, US
Assignee:
The Trustees of Columbia University in the City of New York - New York NY
International Classification:
A61F 2/82 A61F 2/00
US Classification:
623 142, 623 143
Abstract:
This invention provides a stent for implantation in a blood vessel or other tissue, wherein the stent is coated with or contains C3 exoenzyme, a chimeric version thereof or an inhibitor of RhoA. This invention also provides a method for treating or inhibiting the onset of restenosis in a subject which comprises implanting one of the instant stents in the subject's blood vessel.
Andrew Marks - Larchmont NY, US Steven Marx - New York NY, US
International Classification:
A61K031/00 C12Q001/00 A61K031/4741
US Classification:
514/001000, 514/291000, 435/004000
Abstract:
This invention provides methods of preventing cellular migration and of treating cardiovascular diseases and tumor metastasis by increasing cyclin-dependent kinase inhibitor p27 activity, and methods of identifying chemical compounds for use in such treatments.
Andrew Marks - Larchmont NY, US Steven Marx - New York NY, US
International Classification:
A61K031/00
US Classification:
514/001000
Abstract:
This invention provides methods of preventing cellular migration and of treating cardiovascular diseases and tumor metastasis by increasing the intracellular concentration of cyclin-dependent kinase inhibitor p27 or C3 exoenzyme or by decreasing the intracellular concentration of Rho-kinase, and methods of identifying chemical compounds for use in such treatments.
Controlling Pathways That Regulate Muscle Contraction In The Heart
Andrew Marks - Larchmont NY, US Steven Marx - New York NY, US
Assignee:
The Trustees of Columbia University - New York NY
International Classification:
A61K031/00 G01N033/53
US Classification:
435/007100, 514/001000
Abstract:
This invention provides methods of regulating contraction of a subject's heart and of treating heart failure and cardiac arrhythmia. This invention also provides methods of obtaining compounds that bind to, and activate or inhibit the activation of a type 2 ryanodine (RyR2) receptor, and methods for screening for compounds that alleviate heart disease.
Use Of Y-27632 As An Agent To Prevent Restenosis After Coronary Artery Angioplasty/Stent Implantation
Andrew Marks - Larchmont NY, US Steven Marx - New York NY, US
International Classification:
A61K031/537 A61F002/00
US Classification:
424/423000, 514/238200
Abstract:
This invention is directed to a stent for implantation in a blood vessel, wherein the stent is coated with Y-27632. The invention also provides a method of treating restenosis in a subject which comprises implanting in the subject a stent coated with Y-27632.
Medical Devices And Methods For Inhibiting Proliferation Of Smooth Muscle Cells
Steven Marx - New York NY, US Andrew Marks - Larchmont NY, US
International Classification:
A61K038/12 A61K031/19
US Classification:
424/423000, 514/009000, 514/575000
Abstract:
The present invention provides HDAC inhibitors for use in inhibiting proliferation and/or migration of smooth muscle cells. The present invention further provides medical devices coated with the HDAC inhibitors. The present invention also provides use of the medical devices in methods for inhibiting proliferation and/or migration of smooth muscle cells. Additionally, the present invention provides methods for inhibiting proliferation and/or migration of non-neoplastic smooth muscle cells. Finally, the present invention provides methods for preventing or treating restenosis after angioplasty or stent implantation in a subject.
"In some ways it's showing some of the worst sides of what this instant media can do," said Steven Marx, a 48-year-old who had only 17 Twitter followers before the hashtag spread. "It's sort of that mob mentality that Twitter encourages. I think in this sense it's showing the bad. But in the Occupy
Naperville North High School Naperville IL 1996-2000
Community:
Mark Jackson, Christina Slaughter, Stefanie Kunze, David Vrbenec, Chris Shales, John Dickerson, David Aronson, Kamai Westbrooks, Ed Marshinski, Jennifer Risvold